Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

01-10-2018

https://doi.org/10.4081/dr.2018.7859

2140

PDF: 1100

HTML: 91
Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

11-04-2025

https://doi.org/10.4081/dr.2025.10124

711

PDF: 455

HTML: 17
Hidradenitis suppurativa: state-of-the-art review and update

Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola

27-08-2025

https://doi.org/10.4081/dr.2025.10328

1376

PDF: 871

HTML: 23
Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

29-07-2021

https://doi.org/10.4081/dr.2021.8797

3173

PDF: 670

HTML: 20
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1989

PDF: 758

HTML: 54
Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

13-03-2025

https://doi.org/10.4081/dr.2025.10021

545

PDF: 370

HTML: 16
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

21-02-2025

https://doi.org/10.4081/dr.2025.10278

510

PDF: 331

HTML: 27
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

636

PDF: 330

HTML: 26
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

900

PDF: 475

HTML: 54
A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Shinpei Miura, Kanako Tsunoda, Hiroo Amano

05-06-2023

https://doi.org/10.4081/dr.2023.9699

800

PDF: 478

HTML: 33
Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

06-12-2024

https://doi.org/10.4081/dr.2024.10171

1876

PDF: 499

HTML: 65
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1123

PDF: 593

HTML: 98
Isotretinoin musculoskeletal side effects: a systematic review

Rahaf R. Almutairi, Atheer G. Almutairi, Afnan F. Alhallafi, Norah A. Almudawi, Mohammed Abdulaziz AlSulaiman, Asem M. Shadid, Ruaa Alharithy

12-04-2024

https://doi.org/10.4081/dr.2024.9845

6279

PDF: 1232

SUPPLEMENTARY: 470

HTML: 505
Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

Mitchell Hanson, McKenzie E. Maloney, Louis Kuchnir

08-02-2024

https://doi.org/10.4081/dr.2024.9866

1255

PDF: 780

HTML: 41
When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

Chiara Del Re, Vincenzo Filastro, Gaia Fasano, Giancarlo Valenti, Domenico D'Amico

11-09-2026

https://doi.org/10.4081/dr.2026.10808

421

PDF: 186
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1250

PDF: 869

HTML: 50
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1866

PDF: 766

HTML: 109
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1833

PDF: 566

HTML: 102
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1135

PDF: 653

HTML: 51
Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

04-02-2025

https://doi.org/10.4081/dr.2025.10232

576

PDF: 366

HTML: 27
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

30-07-2025

https://doi.org/10.4081/dr.2025.10379

592

PDF: 407

HTML: 15
Treatment modalities of necrobiosis lipoidica: a concise systematic review

Amir Feily, Shadi Mehraban

08-06-2015

https://doi.org/10.4081/dr.2015.5749

3045

PDF: 1932

Suppl. Table: 462

HTML: 503
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1165

PDF: 751

HTML: 75
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1425

PDF: 776

HTML: 19
Secondary prevention of hidradenitis suppurativa

Hjalmar Kurzen, Marina Kurzen

25-10-2019

https://doi.org/10.4081/dr.2019.8243

3132

PDF: 1255

HTML: 45

1 - 25 of 35 items 1 2 > >>

Search

Search Results

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Hidradenitis suppurativa: state-of-the-art review and update

Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Certolizumab to treat hidradenitis suppurativa

Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Isotretinoin musculoskeletal side effects: a systematic review

Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Treatment modalities of necrobiosis lipoidica: a concise systematic review

A microRNA focus on acne

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Secondary prevention of hidradenitis suppurativa

authors

reviewers

Categories

indexing

dermatopathology